|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/337 | (2006.01) |
| A61K 31/416 | (2006.01) | ||
| A61K 31/513 | (2006.01) | ||
| A61K 31/517 | (2006.01) | ||
| A61K 31/5355 | (2006.01) | ||
| A61K 31/555 | (2006.01) | ||
| A61K 39/395 | (2006.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| C07K 16/32 | (2006.01) |
| (11) | Patento numeris | 3269366 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17167567.1 |
| Europos patento paraiškos padavimo data | 2009-03-10 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-01-17 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-01-15 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 37410 P | 2008-03-18 | US |
| (72) |
BERRY, Leanne, US
PHILLIPS, Gail, Lewis, US
SLIWKOWSKI, Mark, X., US
|
| (73) |
Genentech, Inc.,
1 DNA Way, South San Francisco, CA 94080,
US
|
| (54) | COMBINATIONS OF AN ANTI-HER2 ANTIBODY-DRUG CONJUGATE AND LAPATINIB, AND METHODS OF USE |
| COMBINATIONS OF AN ANTI-HER2 ANTIBODY-DRUG CONJUGATE AND LAPATINIB, AND METHODS OF USE |